Oyster Point Pharma
We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
$16.00 - $18.00
October 31, 2019
J.P. MORGAN SECURITIES LLC,COWEN AND COMPANY, LLC,PIPER JAFFRAY & CO.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Oyster Point Pharma IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277